CLINICAL_TRIALS
trial_result
· 2020-01-18
Clinical Trial Update: Dasotraline Pediatric Extension Study [Phase 3]
Summary
Phase 3 pediatric extension study of dasotraline for ADHD has completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2020-01-18